Tuberculosis (TB) is the main cause of death amongst human immunodeficiency virus (HIV)-infected individuals worldwide, while 14 million people are estimated to be dually infected [1]. In Europe only, the estimated number of deaths from TB in HIV infected patients exceeded 5100 in 2016. What is more, in EU/EEA countries coinfection was most prevalent amongst males and those between ages 25–44 years [2]. A recent study has shown that migration has played a major role in the increasing numbers of co-infected individuals in Europe, as migrants coming from a low-income background were shown to be more susceptible to co-infection compared to national population.
